UB Paderborn / Katalog / Suche / in CDI

The Lipid-Lowering Effect of Tenofovir/Emtricitabine: A Randomized, Crossover, Double-Blind, Placebo-Controlled Trial

Clinical infectious diseases, 2015-08, Vol.61 (3), p.403-408

2015

Link zum Volltext

Verfügbarkeit prüfen

In Vivo, Non-Invasive Characterization of Human Bone by Hybrid Broadband (600-1200 nm) Diffuse Optical and Correlation Spectroscopies

PloS one, 2016-12, Vol.11 (12), p.e0168426-e0168426

2016

Link zum Volltext

Verfügbarkeit prüfen

Effects of integrase inhibitor-based antiretroviral therapy on brain outcomes according to time since acquisition of HIV-1 infection

Scientific reports, 2021-05, Vol.11 (1), p.11289-11289, Article 11289

2021

Link zum Volltext

Verfügbarkeit prüfen

High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort study

AIDS (London), 2010-11, Vol.24 (18), p.2827-2833

2010

Link zum Volltext

Verfügbarkeit prüfen

A randomized pilot trial to evaluate the benefit of the concomitant use of atorvastatin and Raltegravir on immunological markers in protease-inhibitor-treated subjects living with HIV

PloS one, 2020-09, Vol.15 (9), p.e0238575-e0238575

2020

Link zum Volltext

Verfügbarkeit prüfen

Identifying the needs of older people living with HIV (≥ 50 years old) from multiple centres over the world: a descriptive analysis

AIDS research and therapy, 2023-02, Vol.20 (1), p.10-10, Article 10

2023

Link zum Volltext

Verfügbarkeit prüfen

Adipokines as New Biomarkers of Immune Recovery: Apelin Receptor, RBP4 and ZAG Are Related to CD4 + T-Cell Reconstitution in PLHIV on Suppressive Antiretroviral Therapy

International journal of molecular sciences, 2022-02, Vol.23 (4), p.2202

2022

Link zum Volltext

Verfügbarkeit prüfen

Measurement of Intracellular Didanosine and Tenofovir Phosphorylated Metabolites and Possible Interaction of the Two Drugs in Human Immunodeficiency Virus-Infected Patients

Antimicrobial Agents and Chemotherapy, 2005-05, Vol.49 (5), p.1907-1914

2005

Link zum Volltext

Verfügbarkeit prüfen

Low nadir CD4+ T-cell counts predict gut dysbiosis in HIV-1 infection

Mucosal immunology, 2019-01, Vol.12 (1), p.232-246

2019

Link zum Volltext

Verfügbarkeit prüfen

Classification models for neurocognitive impairment in HIV infection based on demographic and clinical variables

PloS one, 2014-09, Vol.9 (9), p.e107625-e107625

2014

Link zum Volltext

Verfügbarkeit prüfen

Nadir CD4 T Cell Count as Predictor and High CD4 T Cell Intrinsic Apoptosis as Final Mechanism of Poor CD4 T Cell Recovery in Virologically Suppressed HIV-Infected Patients: Clinical Implications

Clinical infectious diseases, 2010-05, Vol.50 (9), p.1300-1308

2010

Link zum Volltext

Verfügbarkeit prüfen

Different plasma markers of inflammation are influenced by immune recovery and cART composition or intensification in treated HIV infected individuals

PloS one, 2014-12, Vol.9 (12), p.e114142-e114142

2014

Link zum Volltext

Verfügbarkeit prüfen

Randomised study to assess the efficacy and safety of once-daily etravirine-based regimen as a switching strategy in HIV-infected patients receiving a protease inhibitor-containing regimen. Etraswitch study

PloS one, 2014-02, Vol.9 (2), p.e84676

2014

Link zum Volltext

Verfügbarkeit prüfen

Nadir CD4 cell count predicts neurocognitive impairment in HIV-infected patients

AIDS research and human retroviruses, 2008-10, Vol.24 (10), p.1301

2008

Link zum Volltext

Verfügbarkeit prüfen

Raltegravir intensification shows differing effects on CD8 and CD4 T cells in HIV-infected HAART-suppressed individuals with poor CD4 T-cell recovery

AIDS (London), 2012-11, Vol.26 (18), p.2285-2293

2012

Link zum Volltext

Verfügbarkeit prüfen

Early but limited effects of raltegravir intensification on CD4 T cell reconstitution in HIV-infected patients with an immunodiscordant response to antiretroviral therapy

Journal of antimicrobial chemotherapy, 2013-10, Vol.68 (10), p.2358-2362

2013

Link zum Volltext

Verfügbarkeit prüfen

Long-term neuropsychiatric disorders on efavirenz-based approaches: quality of life, psychologic issues, and adherence

Journal of acquired immune deficiency syndromes (1999), 2005-04, Vol.38 (5), p.560

2005

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of single-tablet darunavir, cobicistat, emtricitabine, and tenofovir alafenamide in the treatment of HIV-1

Expert opinion on pharmacotherapy, 2018-06, Vol.19 (8), p.929-934

2018

Link zum Volltext

Verfügbarkeit prüfen

TL1A-DR3 Plasma Levels Are Predictive of HIV-1 Disease Control, and DR3 Costimulation Boosts HIV-1-Specific T Cell Responses

The Journal of immunology (1950), 2020-12, Vol.205 (12), p.3348-3357

2020

Link zum Volltext

Verfügbarkeit prüfen

Hypertension Is a Key Feature of the Metabolic Syndrome in Subjects Aging with HIV

Current Hypertension Reports, 2016-06, Vol.18 (6), p.46-46, Article 46

2016

Link zum Volltext

Verfügbarkeit prüfen

Pilot Pharmacokinetic Study of Human Immunodeficiency Virus-Infected Patients Receiving Tenofovir Disoproxil Fumarate (TDF): Investigation of Systemic and Intracellular Interactions between TDF and Abacavir, Lamivudine, or Lopinavir-Ritonavir

Antimicrobial Agents and Chemotherapy, 2009-05, Vol.53 (5), p.1937-1943

2009

Link zum Volltext

Verfügbarkeit prüfen

Immunodiscordant responses to HAART - mechanisms and consequences

Expert review of clinical immunology, 2013-11, Vol.9 (11), p.1135-1149

2013

Link zum Volltext

Verfügbarkeit prüfen

High risk and probability of progression to osteoporosis at 10 years in HIV-infected individuals: the role of PIs

Journal of antimicrobial chemotherapy, 2018-09, Vol.73 (9), p.2452-2459

2018

Link zum Volltext

Verfügbarkeit prüfen

Multiomics plasma effects of switching from triple antiretroviral regimens to dolutegravir plus lamivudine

Journal of antimicrobial chemotherapy, 2024-05, Vol.79 (5), p.1133-1141

2024

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

The Lipid-Lowering Effect of Tenofovir/Emtricitabine: A Randomized, Crossover, Double-Blind, Placebo-Controlled Trial

Gut Microbiota Linked to Sexual Preference and HIV Infection

In Vivo, Non-Invasive Characterization of Human Bone by Hybrid Broadband (600-1200 nm) Diffuse Optical and Correlation Spectroscopies

Effects of integrase inhibitor-based antiretroviral therapy on brain outcomes according to time since acquisition of HIV-1 infection

High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort study

A randomized pilot trial to evaluate the benefit of the concomitant use of atorvastatin and Raltegravir on immunological markers in protease-inhibitor-treated subjects living with HIV

Identifying the needs of older people living with HIV (≥ 50 years old) from multiple centres over the world: a descriptive analysis

Adipokines as New Biomarkers of Immune Recovery: Apelin Receptor, RBP4 and ZAG Are Related to CD4 + T-Cell Reconstitution in PLHIV on Suppressive Antiretroviral Therapy

Measurement of Intracellular Didanosine and Tenofovir Phosphorylated Metabolites and Possible Interaction of the Two Drugs in Human Immunodeficiency Virus-Infected Patients

Low nadir CD4+ T-cell counts predict gut dysbiosis in HIV-1 infection

Classification models for neurocognitive impairment in HIV infection based on demographic and clinical variables

Nadir CD4 T Cell Count as Predictor and High CD4 T Cell Intrinsic Apoptosis as Final Mechanism of Poor CD4 T Cell Recovery in Virologically Suppressed HIV-Infected Patients: Clinical Implications

Different plasma markers of inflammation are influenced by immune recovery and cART composition or intensification in treated HIV infected individuals

Randomised study to assess the efficacy and safety of once-daily etravirine-based regimen as a switching strategy in HIV-infected patients receiving a protease inhibitor-containing regimen. Etraswitch study

Nadir CD4 cell count predicts neurocognitive impairment in HIV-infected patients

Raltegravir intensification shows differing effects on CD8 and CD4 T cells in HIV-infected HAART-suppressed individuals with poor CD4 T-cell recovery

Early but limited effects of raltegravir intensification on CD4 T cell reconstitution in HIV-infected patients with an immunodiscordant response to antiretroviral therapy

Long-term neuropsychiatric disorders on efavirenz-based approaches: quality of life, psychologic issues, and adherence

Efficacy of single-tablet darunavir, cobicistat, emtricitabine, and tenofovir alafenamide in the treatment of HIV-1

TL1A-DR3 Plasma Levels Are Predictive of HIV-1 Disease Control, and DR3 Costimulation Boosts HIV-1-Specific T Cell Responses

Hypertension Is a Key Feature of the Metabolic Syndrome in Subjects Aging with HIV

Pilot Pharmacokinetic Study of Human Immunodeficiency Virus-Infected Patients Receiving Tenofovir Disoproxil Fumarate (TDF): Investigation of Systemic and Intracellular Interactions between TDF and Abacavir, Lamivudine, or Lopinavir-Ritonavir

Immunodiscordant responses to HAART - mechanisms and consequences

High risk and probability of progression to osteoporosis at 10 years in HIV-infected individuals: the role of PIs

Multiomics plasma effects of switching from triple antiretroviral regimens to dolutegravir plus lamivudine

Suchergebnisse filtern